Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Jul. 31, 2020
Jan. 31, 2020
Current Assets    
Cash $ 95 $ 0
Interest receivable 27,616 0
Inventory 15 0
Other current assets - related party 500,000 0
Total current assets 527,726 0
Convertible notes receivable from related party 1,400,000 0
Total assets 1,927,726 0
Current liabilities    
Accounts payable and accrued expenses 60,096 48,940
Accounts payable related party 112,000 254,495
Due to related party 334,813 304,072
Total current liabilities 506,909 607,507
Total liabilities 506,909 607,507
Stockholders' equity    
Common stock, $0.0001 par value, voting; 200,000,000 shares authorized;5,860,158 and 10,460,000 shares issued and outstanding, as of July 31, 2020 and January 31, 2020, respectively. 586 1,046
Additional paid in capital 54,824,032 3,500,892
Accumulated deficit (53,403,881) (4,109,445)
Total stockholders' equity 1,420,817 (607,507)
Total liabilities and stockholders' equity 1,927,726 0
Series A Preferred Stock [Member]    
Stockholders' equity    
Series A Preferred stock, $0.0001 par value; 1,000,000 shares authorized;150,000 and 0 shares issued and outstanding, as of July 31, 2020 and January 31, 2020, respectively. 15 0
Series B Preferred Stock [Member]    
Stockholders' equity    
Series A Preferred stock, $0.0001 par value; 1,000,000 shares authorized;150,000 and 0 shares issued and outstanding, as of July 31, 2020 and January 31, 2020, respectively. $ 65 $ 0